Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson
vor 4 Jahren
This episode I discuss medical research on psychedelic compounds
with Dr. Matthew Johnson, Professor of Psychiatry and Behavioral
Sciences at Johns Hopkins School of Medicine. We discuss the
biology and medical clinical-trial uses of psilocybin, MDMA,...
Podcast
Podcaster
Beschreibung
vor 4 Jahren
This episode I discuss medical research on psychedelic compounds
with Dr. Matthew Johnson, Ph.D., Professor of Psychiatry and
Behavioral Sciences at Johns Hopkins School of Medicine. We discuss
the biology and medical clinical-trial uses of psilocybin, MDMA,
ayahuasca, DMT, and LSD. Dr. Johnson teaches us what the
clinical trials in his lab are revealing about the potential these
compounds hold for the treatment of depression, addiction, trauma,
eating disorders, ADHD, and other disorders of the mind. Dr.
Johnson describes a typical psychedelic experiment in his
laboratory, start to finish, including the conditions for optimal
clinical outcomes. And he explains some of the potential hazards
and common misconceptions and pitfalls related to psychedelic
medicine. Dr. Johnson explains flashbacks, the heightened risks of
certain people and age groups using psychedelics and the ever
evolving legal and pharmaceutical industry landscape surrounding
psychedelics. Dr. Johnson also explains how the scientific study of
psychedelics is likely to set the trajectory of psychiatric
medicine in the years to come. Dr. Johnson is among a small handful
of researchers who have pioneered the clinical study of these
powerful compounds. He has unprecedented insight into how they can
be woven into other psychiatric treatments, changing ones sense of
self and of reality. Read the full show notes for this episode at
hubermanlab.com. Thank you to our sponsors AG1:
https://athleticgreens.com/huberman LMNT:
https://drinklmnt.com/hubermanlab Waking Up:
https://wakingup.com/huberman Momentous:
https://livemomentous.com/huberman Timestamps 00:00:00 Introducing
Dr. Matthew Johnson 00:02:27 Sponsors: AG1,
LMNT & Waking Up 00:06:40 ‘Psychedelics’
Defined 00:14:09 Hallucinations, Synesthesia, Altered
Space-Time Perception 00:19:56 Serotonin &
Dopamine 00:23:50 Ketamine & Glutamate
00:28:00 An Example Psychedelic Experiment 00:37:30
‘Letting Go’ with Psychedelics 00:44:10 Our Mind’s
Eye 00:48:00 Redefining Your Sense of Self
00:58:56 Exporting Psychedelic Learnings to Daily Life
01:04:36 Flashbacks 01:12:10 Ayahuasca, ASMR, Kundalini
Breathing 01:15:54 MDMA, DMT 01:26:00
Dangers of Psychedelics, Bad Trips, Long-Lasting
Psychosis 01:38:15 Micro-Dosing 01:56:45
Risks for Kids, Adolescents & Teenagers; Future Clinical
Trials 02:03:40 Legal Status: Decriminalization vs.
Legalization vs. Regulation 02:18:35 Psychedelics for
Treating Concussion & Traumatic Brain Injury
02:27:45 Shifting Trends in Psychedelic Research, Academic
Culture 02:44:23 Participating in a Clinical Trial,
Online Survey Studies, Breathwork 02:50:38 Conclusions,
Subscribing & Supporting the HLP, Supplements
Disclaimer & Disclosures Learn more about your ad choices.
Visit megaphone.fm/adchoices
with Dr. Matthew Johnson, Ph.D., Professor of Psychiatry and
Behavioral Sciences at Johns Hopkins School of Medicine. We discuss
the biology and medical clinical-trial uses of psilocybin, MDMA,
ayahuasca, DMT, and LSD. Dr. Johnson teaches us what the
clinical trials in his lab are revealing about the potential these
compounds hold for the treatment of depression, addiction, trauma,
eating disorders, ADHD, and other disorders of the mind. Dr.
Johnson describes a typical psychedelic experiment in his
laboratory, start to finish, including the conditions for optimal
clinical outcomes. And he explains some of the potential hazards
and common misconceptions and pitfalls related to psychedelic
medicine. Dr. Johnson explains flashbacks, the heightened risks of
certain people and age groups using psychedelics and the ever
evolving legal and pharmaceutical industry landscape surrounding
psychedelics. Dr. Johnson also explains how the scientific study of
psychedelics is likely to set the trajectory of psychiatric
medicine in the years to come. Dr. Johnson is among a small handful
of researchers who have pioneered the clinical study of these
powerful compounds. He has unprecedented insight into how they can
be woven into other psychiatric treatments, changing ones sense of
self and of reality. Read the full show notes for this episode at
hubermanlab.com. Thank you to our sponsors AG1:
https://athleticgreens.com/huberman LMNT:
https://drinklmnt.com/hubermanlab Waking Up:
https://wakingup.com/huberman Momentous:
https://livemomentous.com/huberman Timestamps 00:00:00 Introducing
Dr. Matthew Johnson 00:02:27 Sponsors: AG1,
LMNT & Waking Up 00:06:40 ‘Psychedelics’
Defined 00:14:09 Hallucinations, Synesthesia, Altered
Space-Time Perception 00:19:56 Serotonin &
Dopamine 00:23:50 Ketamine & Glutamate
00:28:00 An Example Psychedelic Experiment 00:37:30
‘Letting Go’ with Psychedelics 00:44:10 Our Mind’s
Eye 00:48:00 Redefining Your Sense of Self
00:58:56 Exporting Psychedelic Learnings to Daily Life
01:04:36 Flashbacks 01:12:10 Ayahuasca, ASMR, Kundalini
Breathing 01:15:54 MDMA, DMT 01:26:00
Dangers of Psychedelics, Bad Trips, Long-Lasting
Psychosis 01:38:15 Micro-Dosing 01:56:45
Risks for Kids, Adolescents & Teenagers; Future Clinical
Trials 02:03:40 Legal Status: Decriminalization vs.
Legalization vs. Regulation 02:18:35 Psychedelics for
Treating Concussion & Traumatic Brain Injury
02:27:45 Shifting Trends in Psychedelic Research, Academic
Culture 02:44:23 Participating in a Clinical Trial,
Online Survey Studies, Breathwork 02:50:38 Conclusions,
Subscribing & Supporting the HLP, Supplements
Disclaimer & Disclosures Learn more about your ad choices.
Visit megaphone.fm/adchoices
Weitere Episoden
3 Stunden 16 Minuten
vor 3 Monaten
39 Minuten
vor 3 Monaten
2 Stunden 30 Minuten
vor 3 Monaten
41 Minuten
vor 3 Monaten
2 Stunden 14 Minuten
vor 4 Monaten
Abonnenten
Berlin
Kommentare (0)
Melde Dich an, um einen Kommentar zu schreiben.